Major Novartis Shareholder Calls For Board Shake-Up After Drug Trial Setbacks
Macro·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novartis’ recent dual clinical setbacks have prompted questions from a major shareholder about the board’s oversight of dealmaking.
The shareholder is calling for a board overhaul following these costly deal setbacks.
Novartis
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks”
Yahoo Finance — Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks“Novartis’ recent dual clinical setbacks have prompted questions from a major shareholder about the board’s oversight of dealmaking.”
fierce biotech — <a href="/pharma/novartis-shareholder-calls-board-overhaul-following-costly-deal-setbacks-reuters" hreflang="en">Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters</a>